Loading stock data...

Anuh Pharma Limited

BSE: ANUHPHR

BSE
171.55 -2.15 (-1.24%)

Prev Close

173.7

Open Price

171.5

Volume

6,923

Today Low / High

170.5 / 175.45

52 WK Low / High

148.05 / 241.35

Range

163 - 180

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 171.55, reflecting a change of -2.15 (-1.23777%). The expected target range on the BSE is 163 - 180. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

17 Apr 174.00 -1.41%
16 Apr 175.30 -0.91%
15 Apr 179.05 -2.76%
11 Apr 171.50 0.20%
09 Apr 169.05 -1.36%
08 Apr 170.85 -1.00%
07 Apr 166.70 -1.20%
04 Apr 187.55 -5.95%
03 Apr 167.40 9.56%
02 Apr 154.00 6.53%
01 Apr 151.30 1.39%
28 Mar 151.85 -1.98%
27 Mar 150.95 -1.13%
26 Mar 158.20 -5.09%
25 Mar 160.10 -2.19%
24 Mar 157.00 2.26%
21 Mar 159.00 -0.44%
20 Mar 157.00 -0.92%

Anuh Pharma Limited Graph

Anuh Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Anuh Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 171.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 171.55 173.27 155.94 - 190.59
174.98 139.98 - 209.98
176.70 123.69 - 229.71
Bearish Scenario 171.55 169.83 152.85 - 186.82
168.12 134.50 - 201.74
166.40 116.48 - 216.32

Overview of Anuh Pharma Limited

ISIN

INE489G01022

Industry

Medical - Pharmaceuticals

Vol.Avg

13,727

Market Cap

8,596,713,600

Last Dividend

2.5

Official Website

Visit Website

IPO Date

2002-07-08

DCF Diff

-14.85

DCF

186

Financial Ratios Every Investor Needs

Stock Dividend of ANUHPHR

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-08-16 August 16, 24 2.5 2.5 2024-08-16 2024-09-22
2023-08-11 August 11, 23 2 2 2023-08-11 2023-09-17
2022-08-03 August 03, 22 1.75 1.75 2022-08-04 2022-09-04
2021-08-17 August 17, 21 1.5 1.5 2021-08-18 2021-09-18
2020-03-05 March 05, 20 1.375 2.75 2020-03-06 2020-03-22

Stock Rating Details for ANUHPHR

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 647.00 Cr 486.66 Cr 160.34 Cr 0.2478 0.00 Cr 1.96 Cr 68.22 Cr 60.06 Cr 11.98 87.85 Cr 0.0928
2023-03-31 527.49 Cr 401.48 Cr 126.00 Cr 0.2389 0.00 Cr 1.47 Cr 45.04 Cr 36.18 Cr 7.22 57.92 Cr 0.0686
2022-03-31 486.65 Cr 377.68 Cr 108.97 Cr 0.2239 0.00 Cr 1.33 Cr 37.76 Cr 30.56 Cr 6.10 52.66 Cr 0.0628
2021-03-31 431.96 Cr 329.80 Cr 102.16 Cr 0.2365 0.00 Cr 1.38 Cr 30.98 Cr 28.44 Cr 5.67 55.66 Cr 0.0658
2020-03-31 306.96 Cr 230.16 Cr 76.80 Cr 0.2502 3.00 Cr 1.26 Cr 23.55 Cr 14.31 Cr 2.85 27.45 Cr 0.0466

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 7.20 Cr 445.68 Cr 154.46 Cr 291.2179 Cr 2.69 Cr -4.51 Cr 77.74 Cr 49.24 Cr 3.24 Cr 0.00 Cr 54.92 Cr 152.6938 Cr
2023-03-31 1.93 Cr 404.98 Cr 163.76 Cr 241.2212 Cr 0.91 Cr -1.02 Cr 72.64 Cr 52.68 Cr 3.13 Cr 0.00 Cr 39.68 Cr 161.3352 Cr
2022-03-31 3.80 Cr 347.17 Cr 133.40 Cr 213.7728 Cr 4.22 Cr 0.43 Cr 79.99 Cr 61.34 Cr 1.41 Cr 0.00 Cr 24.76 Cr 130.9058 Cr
2021-03-31 2.20 Cr 332.64 Cr 142.00 Cr 190.6435 Cr 13.68 Cr 11.48 Cr 81.55 Cr 71.18 Cr 0.66 Cr 0.00 Cr 20.87 Cr 139.4693 Cr
2020-03-31 1.85 Cr 326.37 Cr 164.17 Cr 162.2074 Cr 45.15 Cr 43.31 Cr 61.49 Cr 83.75 Cr 4.39 Cr 0.00 Cr -52.17 Cr 162.7090 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 13.8244 Cr -0.2296 Cr -8.3199 Cr 8.8078 Cr 5.2749 Cr 7.2017 Cr -5.0166 Cr 60.0575 Cr 2.0134 Cr -10.0254 Cr -2.7639 Cr
2023-03-31 53.9016 Cr -43.4837 Cr -12.2869 Cr 52.3515 Cr -1.8690 Cr 1.9268 Cr -1.5501 Cr 47.4704 Cr -3.1110 Cr -8.7483 Cr 7.2870 Cr
2022-03-31 28.8637 Cr -7.8171 Cr -19.4492 Cr 27.2489 Cr 1.5974 Cr 3.7958 Cr -1.6148 Cr 39.1220 Cr -10.4867 Cr -7.5577 Cr 1.5025 Cr
2021-03-31 -18.7347 Cr 52.2029 Cr -33.1150 Cr -24.8885 Cr 0.3532 Cr 2.1984 Cr -6.1538 Cr 38.5514 Cr -30.9623 Cr 0.0000 Cr -19.9383 Cr
2020-03-31 48.9307 Cr -76.5296 Cr 22.1717 Cr 13.3014 Cr -5.4272 Cr 1.8452 Cr -35.6293 Cr 19.1556 Cr 40.1743 Cr -16.6540 Cr -18.6367 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 159.51 Cr 120.48 Cr 39.04 Cr 0.2447 12.61 Cr 10.34 Cr 2.06 15.73 Cr 0.0648
2024-09-30 165.95 Cr 125.23 Cr 40.72 Cr 0.2454 14.96 Cr 15.04 Cr 3.00 20.28 Cr 0.0906
2024-06-30 137.91 Cr 112.22 Cr 25.69 Cr 0.1863 8.69 Cr 9.51 Cr 1.90 14.29 Cr 0.0690
2024-03-31 163.89 Cr 127.82 Cr 36.07 Cr 0.2201 17.00 Cr 15.36 Cr 3.06 22.05 Cr 0.0937
2023-12-31 172.10 Cr 125.79 Cr 46.31 Cr 0.2691 21.79 Cr 19.11 Cr 3.81 27.65 Cr 0.1111

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 2.97 Cr 49.27 Cr 52.24 Cr 0.00 Cr 71.10 Cr 314.44 Cr 47.63 Cr 434.19 Cr 131.08 Cr
2024-03-31 7.20 Cr 55.05 Cr 62.26 Cr 193.13 Cr 77.74 Cr 336.20 Cr 49.24 Cr 445.68 Cr 154.46 Cr
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 12.79 Cr 44.19 Cr 56.98 Cr 150.70 Cr 76.84 Cr 292.27 Cr 52.61 Cr 399.73 Cr 142.99 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 19.11 Cr 19.11 Cr 0.00 Cr 0.00 Cr 4.63 Cr 19.11 Cr 14.49 Cr 0.00 Cr 19.11 Cr
2023-09-30 13.83 Cr 13.83 Cr 0.00 Cr 0.00 Cr 13.83 Cr 14.49 Cr 0.65 Cr 0.00 Cr 13.83 Cr
2023-06-30 11.75 Cr 11.75 Cr 0.00 Cr 0.00 Cr 6.60 Cr 11.75 Cr 5.15 Cr 0.00 Cr 11.75 Cr
2023-03-31 9.62 Cr 9.62 Cr 0.00 Cr 0.00 Cr 9.62 Cr 5.15 Cr -4.47 Cr 0.00 Cr 9.62 Cr
2022-12-31 9.31 Cr 9.31 Cr 0.00 Cr 0.00 Cr -1.58 Cr 9.31 Cr 10.89 Cr 0.00 Cr 9.31 Cr

Splits History

Date Label Split Ratio
2020-09-18 September 18, 20 2:1
2015-08-05 August 05, 15 3:1
2010-10-28 October 28, 10 3:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹795.30 ₹95,148,896,700.00 ₹151,791.00

Key Executives

Joint MD & Executive Director
Mr. Vivek Bipin Shah M.Sc

Gender: male

Year Born: 1986

Joint MD & Executive Director
Mr. Ritesh Bipin Shah MBA

Gender: male

Year Born: 1981

Vice President of Marketing
Mr. Rajendrakumar C. Kotadia

Gender: male

Year Born: 1964

Non-Executive Vice Chairman of the Board
Mr. Bipin Nemchand Shah

Gender: male

Year Born: 1949

Chief Financial Officer
Mr. Darshan Dhirajlal Rampariya

Gender: male

Year Born:

Company Secretary & Compliance Officer
Mr. Manan Jayesh Vadhan

Gender: male

Year Born:

Assistant General Manager of Technical
Mr. Babu K. Moghaveera

Gender: male

Year Born:

FAQs about Anuh Pharma Limited

Who is the CEO of the company?

The CEO is Mr. Ritesh Bipin Shah MBA.

What is the current market price of the stock?

The current price is ₹171.55.

What is the 52-week price range?

The range is ₹148.05-241.35.

What is the market capitalization of the company?

The market capitalization is ₹859.67 crores.

What is the dividend yield?

The dividend yield is 1.46%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.14.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Anuh Pharma Limited (ISIN: INE489G01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹859.67 crores and an average daily volume of 13,727 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹2.5.